Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Tizanidine Hydrochloride API

Product
  • Therapeutic Category 中枢神経系 (CNS)

  • CAS Number

    64461-82-1

  • API Technology

    Synthetic

  • Dose Form

    Capsule/ Tablet

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, EUDMF, CEP DMF Filed

Mechanism of Action

Tizanidine is a central alpha-2-adrenergic receptor agonist and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons.

Indication

Zanaflex is a central alpha-2-adrenergic agonist indicated for the management of spasticity

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

エスゾピクロン

中枢神経系 (CNS)

arrow

エダラボン

中枢神経系 (CNS)

arrow

アプレミラスト(非晶質およびB型)

中枢神経系 (CNS)

arrow

アトモキセチン塩酸塩

中枢神経系 (CNS)

arrow

ジメチルフマル酸塩

中枢神経系 (CNS)

arrow

エスリカルバゼピン酢酸塩

中枢神経系 (CNS)

arrow

フルオキセチン

中枢神経系 (CNS)

arrow

レベチラセタム

中枢神経系 (CNS)

arrow

ルマテペロントシル酸塩

中枢神経系 (CNS)

arrow

メマンチン塩酸塩

中枢神経系 (CNS)

arrow

プレガバリン

中枢神経系 (CNS)

arrow

クエチアピンフマル酸塩

中枢神経系 (CNS)

arrow

リスペリドン

中枢神経系 (CNS)

arrow

リバスチグミン酒石酸塩

中枢神経系 (CNS)

arrow

ロピニロール

中枢神経系 (CNS)

arrow

スガマデクスナトリウム

中枢神経系 (CNS)

arrow

ザノメリン

中枢神経系 (CNS)

arrow

ジプラシドン塩酸塩無水物

中枢神経系 (CNS)

arrow

チザニジン塩酸塩

中枢神経系 (CNS)

arrow

ベンザトロピンメシル酸塩

中枢神経系 (CNS)

arrow

シポニモドヘミフマル酸塩

中枢神経系 (CNS)

arrow

オランザピン(I型)

中枢神経系 (CNS)

arrow

ドネペジル塩酸塩

中枢神経系 (CNS)

arrow

ルラシドン

中枢神経系 (CNS)

arrow

免責事項

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.